Comparing use of Tablet Tamsulosin with a combination of Tamsulosin and Deflazacort for clearance of ureteric stones less than 8 mm.
Phase 3
- Conditions
- Health Condition 1: N201- Calculus of ureter
- Registration Number
- CTRI/2024/03/063952
- Lead Sponsor
- Gautam Girish
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)All patients who report to emergency/ Urology OPD with ureteric calculi 8 mm or less in size
2)Willing to consent for the study
Exclusion Criteria
Patient with urinary tract infection based on urine routine analysis and fever
Uncontrolled pain
Impaired kidney function Serum creatinine more than 1.4 mg/dl
Solitary kidney
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess stone expulsion rates on treatment with alpha blockers (Tamsulosin) and in combination with corticosteroids (Tamsulosin and Deflazacort) in patients diagnosed with distal ureteric calculus (less than 8mm)Timepoint: Stone expulsion rate assessed at 2 weeks or when patient gives history of passage of stone whichever is earlier
- Secondary Outcome Measures
Name Time Method To assess stone expulsion rates on treatment with alpha blockers Tamsulosin alone and in combination with corticosteroids Tamsulosin and Deflazacort in patients diagnosed with ureteric calculus less than 8mm at 2 weeks <br/ ><br>To assess stone expulsion based on size of stone less than 5mm and between 5 to 8 mm <br/ ><br>Quantification of Analgesics using analgesic quantification score <br/ ><br>Average time of stone clearance on NCCT KUB on history of passage of stone or at 02 weeks whichever is earlier <br/ ><br>Timepoint: 2 weeks